USE OF DEXAMETHASONE FOR THE TREATMENT OF SEVERE COVID-19 2020-08-26T18:05:37+02:00Jun 18th, 2020|MAC Advisories| MAC Memo – use of dexamethasone for treatment of severe COVID-19_180620 facebooktwitterlinkedinwhatsappEmail Related Posts RESPONSE TO THE IDENTIFICATION OF A NEW VARIANT (OMICRON) Background document supporting the recommendations for selective vaccination of children 12-17 years old with COVID-19 vaccines in South Africa. BACKGROUND DOCUMENT MANDATORY COVID-19 VACCINATIONS IN CERTAIN WORKPLACES MAC Advisory: MITIGATING THE IMPACT OF COVID-19 DURING THE MUNICIPAL ELECTIONS – UPDATE
